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The human receptor for complement fragments C3b and C4b (complement
receptor type I, CR1) is found on erythrocytes, peripheral blood leukocytes,
glomerular podocytes, and follicular dendritic cells and has an important role in
the processing and clearance of C3b/C4b-coated microorganisms and immune
complexes (1, 2) . CR 1 also acts as a cofactor for the factor 1-mediated cleavage
of C3b andC4b (3, 4), a function that might be especially relevant to the finding
of a soluble form of CR1 in plasma (5). This regulatory capacity also suggested
that CR1 was related to factor H and C4-binding protein (C4BP),' and these
three proteins were subsequently shown to share arepeating 60-amino-acid motif
in their primary sequence and to be genetically linked (6-9) .
An unusual structural characteristic of the CR 1 polypeptide chain is the
existence of four allotypic forms differing in M, by >100,000 without apparent
major functional differences (10-14) . The two most common allotypes, termed
F and S, have M, of 250,000 and 290,000, respectively, when analyzed by SDS-
PAGE underreducing conditions, and M, of235,000 and 275,000 after removal
of N-linked oligosaccharides (10) . Biosynthetic studies (15) have confirmed the
inability of glycosylation differences to account for the allotypically different
forms ofCR1 . A third rarer allotype designated F' has an Mr of 210,000 and a
fourth variant hasalso been described that apparently is larger than the S allotype
(12, 13, 16) .
The recent identification and sequencing ofcDNA clones ofCR1 has revealed
the presence of long homologous repeats as another unusual structural charac-
teristic (17) . Each homologous repeat is -1 .3-1 .4 kb, encoding peptide sequences
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of46,000-52,000, and comparison of two repeats indicated 87% nucleotide and
83% amino acid identity (6). The existence of the long homologous repeats
suggests that a possible mechanism for the generation of the CRI allotypes may
be the addition or deletion of these structural units. The present study addresses
this possibility by defining restriction fragment length polymorphisms (RFLP) of
the CRI gene that are associated with the CR1 allotypes.
Materials and Methods
Southern Blot Analysis.
￿
Genomic DNA was isolated from peripheral blood leukocytes
by proteinase K digestion followed by extraction with phenol/chloroform/isoamylalcohol
(18). 15-20 gg of DNA from each donor were digested overnight by various restriction
enzymes according to conditions recommended by the vendor (New England Biolabs,
Beverly, MA). Digested samples were electrophoresed for 24-48 h in 0.8% agarose in
Tris-acetate buffer (18), were transferred onto Zetabind nylon membranes (AMF-Cuno,
Meriden, CT), and hybridized with 12P-labeledprobes for 36 hat 43 °C in 50% formamide
and 5x SSC. The blots were washed at 65°C in 0.2x SSC and exposed on Kodak XAR
film at -70'C.
Analysis ofRNA by Blot Hybridization.
￿
Total RNA was isolated from PBMC by extrac-
tion with guanidine-HCI and precipitation in ethanol (19). 30 tig of RNA was denatured
by heating to 55°C in 33% formamide and 6.2% formaldehyde, and waselectrophoresed
in 0.8% agarose in MOPS buffer containing 3.7% formaldehyde (20). RNA markers were
purchased from Bethesda Research Laboratories (Bethesda, MD). The RNA was trans-
ferred onto Zetabind nylon membranes, hybridized with s2P-labeled probe, and the blots
were washed in 0.2x SSC at 65 °C.
Genomic Libraries.
￿
DNA from selected donors was exhaustively digested with Bam HI
and size-selected on a 10-40% sucrose gradient (18). The fractions containing DNA
fragments of 12-18 kb were pooled, precipitated in 70% ethanol, and ligated to EMBL-
3 arms (Vector CloningSystems, San Diego, CA). The DNA was packaged and plated on
Escherichia coli strain P2392. Positive phage clones were selected by hybridization of
duplicate nitrocellulose filters with 12p-labeled CRI cDNA probes.
Probes.
￿
The cDNA probes, CRI-1 and CRI-2, are Eco RI fragments of CRI cDNA
clone XT8.3 that had been subdoned in pBR327 (17). CRI-4 is the 381-bp Eco RI
fragment between CRI-I and CR1-2 that was obtained from an overlapping phage clone,
XT6.1 . CRI-I and CR1-2 crosshybridize to each other (17) but neitherhybridizes to CR1-
4 (Fig. IA) .
The genomicprobe, GB1 RI, is a 1 .85-kb Eco RI fragment that contains neither human
repeats nor CRI-1- and CRI-4-hybridizing sequences. This probe was obtained from
XGSB4.2, a 14.5-kb Bam HI fragment of human DNA that had been cloned into EMBL-
3 and selected by hybridization to CRI-1 and CR1-2 (Fig. IB).
The genomic probe, GB2PE, is a PvuII-Bam HI fragment of -400 bp, which also
contains no human repeats or CRI-I- and CR1-4-hybridizing sequences. This probe was
derived from an EMBL-3 clone, XGSB16.1, which contains a CRI-I+, CRI-4+, 14 .5-kb
Bam HI fragment of DNA from an individual having the FS phenotype (Fig. I B). All
probes were labeled with ["P]dCTP by nick translation before use in hybridizations.
CRI Protein Analysis.
￿
The structural phenotypes of CRI of individual donors were
assessed by immunoprecipitation of CRI protein from erythrocyte membranes by YZ-1
monoclonal anti-CRI coupled to Sepharose and analysis of the eluted samples by SDS-
PAGE and silver staining (10, 21).
Statistical Analysis.
￿
The correlations among protein and genomic polymorphisms were
assessed by X2 analyses.
Results
The presence of polymorphisms in the CRI gene was sought by hybridization
of CR 1 cDNA probes to Southern blots of human genomic DNA fragmentsWONG ET AL .
￿
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FIGURE 1 . CR1 cDNA and genomic probes. (A) The black bars denote the overlapping
cDNA clones, XT8.3 and XT6.1 . CR 1-4 is derivedfrom the XT6.1 clone because X8 .3 contains
a deletion of91 by in theCR1-4region . The crosshatched bars represent theEcoRI fragments
that have been subcloned into pBR322 or pBR327 . (B) The black bars represent the 14.5-kb
Bam HI genomic fragments comprising the inserts in clones XGSB4.2 and XGSB16 .1 . The
white boxes designate the regions that hybridize to CR1-1 and CR1-2, and the stippled box
designates the region that hybridizes to CR1-4. The crosshatched bars represent the Eco RI
fragment, GBIR1, and the Pvu II-Barn HI fragment, GB2PE, which were subcloned into
pBR322. The restriction sites are designated as follows : R, Eco RI ; B, Bam HI ; P, Pvu 11 ; Sc,
Sac I and Sm, Sma I .
generated by digestion with a panel of restriction enzymes . Although the cDNA
probes, CR1-1, CR1-2, and CR1-4, constitute only 2 kb of the -9 kb of CR1
mRNA (17), these probes crosshybridize to the sequences present in four to five
long homologous repeats of ^-1 .4 kb each that constitute CR1 coding sequence
(reference 17 and L. B. Klickstein, unpublished observations) . Therefore, the
use of these probes allowed for the analysis of 100-150 kb of genomic DNA.
Frequently occurring polymorphisms were identified when genomic DNA was
digested with Barn HI, Sac I, Eco RV, Hind 111, Pvu II, and Eco Rl .
Genomic Polymorphisms that Correlate with Protein Polymorphisms of CRl .
Genomic DNA from six unrelated individuals having the FF, FS, or SS CRl
structural phenotypes was digested by Bam HI and analyzed by Southern blots1534
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FIGURE 2 .
￿
Autoradiographsof the Southern blots in which CRI-4 and GB2PE were hybrid-
ized to the Bam HI digests of the DNA of donors with different CRI protein phenotypes. A
Hind III digest of X DNA was used as a marker and the positions of these fragments are
designated on the left in kilobases . The position of the 14.5-kb restriction fragment seen in
this blot is indicated at the right . The 17-kb restriction fragment was seen in the Southern
blot shown in Fig. 3 .
using CRI-4 as the probe. In three of the four individuals having the S allotype,
a 14.5-kb fragment was identified that was absent in individuals homozygous for
the F allotype (Fig . 2A) . We could find no fragment present in individuals having
the F allotype that was absent in the SS individuals, therefore, a restriction
fragment allelic to the CRI-4+, 14 .5-kb fragment could not be identified . In one
Black individual having theSS phenotype, the CR1-4+, 14.5-kbBamHI fragment
was not seen (Fig . 2A, donor 5) .
The extent to which the presence of the CR1-4+ 14 .5-kb fragment correlated
with the occurrence of the Sallotypewas determined by performing CR I protein
and DNA analyses on 58 unrelated normal individuals, excluding Black donors .
No individual homozygous for the F allotype exhibited the CRI-4+ , 14.5-kb
fragment, whereas we saw this fragment in 20 of 21 individuals having the S
allotype (X2 = 53 .79, p <0.0005) . Neither of the two persons having the F'
allotype were positive for this 14 .5-kb Bam HI fragment (Table I) .
An intervening sequence probe for the S allotype-associated restriction frag-
ment was obtained by digestion of theDNA from an FS donor with BamHI and
by cloning of the size-selected fragments into EMBL-3 . Clones were selected by
hybridization with CRI-4 and CRI-1, and one clone hybridizing with bothTABLE I
Correlation ofS Phenotype with the 14.5-kbBam HI RFLP
WONG ET AL.
￿
1535
probes and containing an insert of 14 .5 kb, termed XGSB 16.1, was restriction
mapped (Fig. 1 B) . The Pvu II-Bam HI fragment, GB2PE, which contained
neither human repeats nor CRI-1- and CRI-4-like sequences, hybridized to the
14.5-kbBam HI fragment characteristic ofan S allele and to nonallelic fragments
of 9.9 and 8.3 kb in individuals of both SS and FF phenotypes (Fig. 2B) .
Therefore, a noncoding genomic sequence that may be repeated once in the F
allele of CR 1 is repeated an additional time in the S allele.
The same blots were probed with CRI-1, which also identifies a 14.5-kb Bam
HI fragment in 20 of the 21 individuals expressing the S allotype (Fig. 3A and
Table I) . In addition, 4 of the 35 FF individuals also had a CRI-I+ 14 .5-kb
fragment, in contrast to the absence of a fragment of this size hybridizing with
CRI-4 in these persons (Figs. 2A and 3A, donor 3 ; Table 1). These findings
suggested that CR1-1, in addition to identifying the 14.5-kb restriction fragment
that was associated with the S allotype, also identified a comigrating Bam HI
fragment that was CRI-4- and not associated with the S allotype. In the same
Black individual having the SS phenotype and lacking the CRI-4+, 14.5-kb Bam
HI fragment, CR1-1 identified a fragment of only 13 kb (Fig. 3A).
We showed the existence of this additional polymorphic Barn HI fragment by
the isolation of a clone termed XGSB4.2, which contained a CRI-1+, CRI-4-,
14.5-kb fragment, from a human genomic library constructed in EMBL-3 from
size-selected, Bam HI-digested DNA. An Eco RI fragment of 1 .85 kb, GB 1 R 1,
that did not hybridize with CRI-1, CRI-4, or human repeat sequences, was
subcloned from XGSB4.2 (Fig. I B). When used as a probe in Southern blot
analyses, GBIR1 hybridized to the 14.5-kb Bam HI fragment previously identi-
fied by CRI-1 in the four FF donors (Table I; Fig. 3, A and B, donor 3) and in
two of the FS donors (Table 1), and did not identify the 14.5-kb Bam HI
fragment characteristic of the SS individuals (Fig. 3 B, donor 1 ; Table I), confirm-
ing its capacity to distinguish between the two comigrating Barn HI fragments.
However, an individual could exhibit both Barn HI polymorphisms since two of
the FS donors had both CR1-4+ and GBIR1+ 14.5-kb Bam HI fragments (Table
1). Also of interest was the finding that this intervening sequence probe, which
did not hybridize to any mRNA species on Northern blot analysis of RNA from
mononuclear cells nor any CR1 cDNA clones, identified two additional fragments
of 17 and 4.6 kb in all individuals (Fig. 3B).
A Southern blot of Barn HI-digested DNA of the Black SS donor who
exhibited a CRI-1+, 13kb Barn HI fragment was probed with GBIR1 . We
identified three fragments of 17, 13, and 4.6 kb (Fig. 3B, donor 5). Thus, the
CRI protein phe-
notype (n)
Presence
CRI-4+
of 14.5-kb
GBIR1+
fragment
CRI-4*/GBIR1+
FF (35) 0 4 0
FS (17) 16 0 2
FF' (2) 0 0 0
SS (4) 4 0 01536
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FIGURE 3 .
￿
Autoradiographs of the Southern blots in which CR1-1 andGBIR1 were hybrid-
ized to the Bam HI digests of the DNA of donors with different CR1 protein phenotypes .
The same blots used in Fig . 2 were probed with CR1-1 (A) and GB2PE (B) and washed as
described. Donors 1-6 correspond to the same individuals shown in Fig . 2 . A Hind III digest
of a DNA was used as a marker and the positions of these fragments are designated on the
left in kilobases . The positions of the 17- and the 14.5-kb restriction fragments are indicated
at the right .
13-kb band seen in this donor was a variant of the GB1R1', 14.5-kb Bam HI
restriction fragment seen in 6 of the 57 normal donors discussed above (Table
I) .
To obtain further evidence for the presence of additional CR1 genomic
sequences in the S allele, DNA from individuals having this allele was digested
with other restriction enzymes, including Apa 1, Bcl 1, Bgl I, Bgl 11, Dra 1, Eco
0109, Eco RI, Eco RV, Hind III, Pst I, Pvu II, Sac I, Taq I, and Xmn I and the
Southern blots were probed with CR1-4. Only Sac I generated a polymorphic
fragment correlating with the occurrence of the CR1-4+ , 14.5-kb Bam HI
fragment . RFLP analyses ofDNA from 57 individuals showed that all 20 donors
of the FS and SS CR1 phenotype who exhibited a CR1-4+, 14.5-kb Bam HI
fragment also exhibited a CR1-4+ , 19-kb Sac I fragment that was absent from
the DNA of the other 35 FF donors. There was no corresponding loss of anyWONG ET AL .
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FIGURE 4 .
￿
Autoradiograph of the Southern blot in which CRI-4 was hybridized to the Sac
1-digested DNA of donors with the Bam HI polymorphisms . Donors 1-4 were identical to
donors 1-4 in Figs . 2 and 3 . Donor 6 wasan FS individual having both CR1-4' and GBIR1'
14.5-kbBamHI fragments . A Hind 111 digest of aDNAwas used asamarker and the positions
of these fragments are designated on the left in kilobases . The positions of the 19- and 7 .9-kb
polymorphic fragments are shown at the right .
fragments in the FF individuals; therefore, an allelic Sac I fragment could not
be identified (Fig . 4) . Sac I also generated a CRI-1+ , CRI-4'} , 7.9-kb restriction
fragment that was present only in the DNA of the four FF donors and two FS
donors who exhibited the CRI-1+, GBIR1+, 14 .5-kb Bam HI fragment (Table
I; represented by donors 3 and 6 in Fig . 4) . The ability to discriminate the two
Bam HI polymorphisms with the use ofanother restriction enzyme confirms that
each polymorphic region arose by mechanisms other than a single base pair
change and is consistent with a polymorphism having arisen by an insertion or
conversion of genomic sequences .
After these RFLPs that correlated with the 290,000 Mr S allotype were
identifed, a genomic polymorphism associated with the 210,000 M, F' allotype
was sought . We saw a CRI-1+ , 18-kb Eco RV fragment in two unrelated donors
who expressed the F and F' allotypes (Fig . 5) . In three generations of the family
ofone of these FF' individuals, the 18-kb Eco RV fragment cosegregated with
the F' allotype (Fig . 5) . This Eco RV restriction fragment was absent in 22 other
donors having the FF and FS phenotypes .
mRNA polymorphisms that correlate with protein polymorphisms.
￿
RNA was iso-
lated from PBMC of individuals expressing the FF', FF, FS, and SS phenotypes
and was analyzed by electrophoresis and blot hybridization with the CR 1 cDNA
probes, CRI-1 and CRI-4 (Fig . 6) . We detected two mRNA species of 7.9 and
9.2 kb in RNA from the FF donor and we also saw two transcripts in an SS
donor, although these were of 9 .2 and 10.7 kb . Only three species of CR 11538
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FIGURE 5 .
￿
Autoradiographsof the Southern blots in which CRI-I was hybridized to the Eco
RV fragments of DNA from donors with different CRI structural allotypes . The left panel
represents samples from three unrelated donors having FF', FF, and FS phenotypes . The
three right panels represent three generations in a family of another unrelated FF' individual .
The three generations are designated by Romannumerals andthemembersofeach generation
are designated in Arabic numerals . A Hind III digest of a DNA was used as a marker and the
positions of these fragments (23, 9.4, and 6 .6 kb) are designated . The position of the 18-kb
restriction fragment characteristic of the F' allotype is shown at the right .
FIGURE 6 .
￿
Autoradiograph oftheNorthern blot in whichCR I cDNA probes were hybridized
to mRNA from individuals having different CRI structural phenotypes . Total RNA isolated
from PBMC of four unrelated individuals were electrophoresed in a 0.8% agarose gel for 24
h . The positions of the RNA standards are designated in kilobases on the left and the relative
sizes of the CRI mRNA bands are shownon the right .
mRNA could be distinguished in the heterozygous FS donor, and the 9.2-kb
species associated with each allele in this individual could not be separated even
when electrophoresis was performed for 48 h rather than 24 h hours . Similarly,
the FF' heterozygoue exhibited only three distinct transcripts, the 6.5-kbmRNA
being unique to the F' allele . A donor homozygous for the F' allele was not
available for analysis to determine if this allele also contributed an additional
transcript, possibly of 7 .9 kb, that comigrated with the smaller species ofmRNA
associated with the F allele . In summary, CRI transcripts increased in length inWONG ET AL.
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TABLE II
Distribution of the Hind III RFLP amongIndividuals with Different
CRI Phenotypes
association with the increased size of the CRI allotypes. This unit of increment
appearedtobe 1.3-1 .4 kb, although thisconclusion is obscured bythe occurrence
of two CRI transcripts for each allele that also differed by ^-1 .4 kb.
Other Genomic Polymorphisms in Linkage Dysequilibrium with CRI Protein Poly-
morphisms. Recently, allelic CRI-1+ Hind III fragments of7.4 and 6.9 kb have
been shown (16) to be associated with high and low numbers, respectively, of
erythrocyte CR1. In the present study, among the eight individuals homozygous
forthe 6.9-kb Hind III fragment, all were foundtoexpressonly the FFphenotype
(Table 11). The association between this Hind III restriction fragment and the F
allotype was significant when subjected to X2 analysis (X2 = 8.79, p <0.025).
Conversely, all four individuals expressing the SS phenotype were homozygous
for the 7.4-kb Hind III fragment and no individual having the S allotype was
homozygous for the 6.9-kb Hind III fragment (Table II), suggesting that the S
allotype is in linkage disequilibrium with the 7.4-kb Hind III fragment.
An additional DNA polymorphism, represented by the presence or absence of
a CRI-4+, 5.8-kb Pvu II fragment, also exhibited linkage dysequilibrium with
the S allotype (Fig. 7). All 12 individuals expressing the S allotype had this Pvu
II fragment, whereas eight of 16 individuals having the FF phenotype lacked
this fragment (Table 111). Thus, the S allotype is significantly associated with the
presence of a CRI-4+, 5.8-kb Pvu II fragment (X2 = 8.4, p <0.005), although
the F allotype may be associated with either the presence or absence of this
restriction fragment. We saw no linkage dysequilibrium between the polymor-
phisms defined by Hind III and Pvu II (data not shown; (X2 = 0.483, p >0.3).
Among the 28 individuals analyzed, an additional CRI-4+ fragment of 4 kb was
also present in one FF individual, indicating the existence of another rarer
polymorphism revealed by the use ofthis restriction enzyme (Fig. 7, donor 5).
A Genomic Polymorphism Identified by CRI cDNA not in Linkage Dysequilibrium
with CRI Allotypes. Another commonly occurring RFLP involving allelic CR1-
I+ fragments of 20 and 16 kb was seen with the use of Eco RI. In a family in
which each parent exhibited only the 20 or the 16 kb fragment, both children
exhibited both restriction fragments (Fig. 8). All members of this family lacked
the CRI-4+ 14.5-kb Bam HI fragments (Fig. 8) and expressed the FF phenotype
(data not shown), indicating that an F allele could be associated with either the
20-kb or the 16-kb Eco RI fragment. A lack of correlation between the Eco RI
polymorphism and CRI protein allotypes was confirmed by analysis of 57
individuals, in whom all three possible genotypes for the Eco RI RFLP were
CRI protein pheno-
type (n) 7.4 kb*
Hind III RFLP
7.4 kb-/6 .9 kb- 6.9 kb+
FF (29) 13 8 8
FS (15) 11 4 0
SS (4) 4 0 01540
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FIGURE 7.
￿
Autoradiograph of the Southern blot in which CRI-4 was hybridized to the Pvu
II fragments ofDNA from donors with different CRI structural allotypes . A Hind III digest
of a DNA was used as a marker and the positions of these fragments are designated on the
left in kilobases . The positions of the 5.8-kb and the 4.0-kb restriction fragments are shown
on the right.
TABLE III
Distribution ofthe Pvu II RFLP amongIndividuals with Different
CRI Phenotypes
found among individuals having the FF, FS, or SS phenotypes (Table IV ; X2 -
1 .52, P>0.2) .
Although this Eco RI RFLP was not in linkage dysequilibrium with the Bam
HI RFLP that is associated with the S allotype, an analysis of an informative
family showed the cosegregation of the 16-kb Eco RI fragment and the CRI-4+ ,
14.5-kb Bam HI fragment (Fig . 9) . Thus, the Eco RI polymorphism is linked to
theCR 1 structural gene but may be relatively distant from the locus determining
the structural phenotype . Frequencies of the alleles bearing the 20- or 16-kb Eco
RI fragments were 54.5 and 45.5%, respectively, in the normal population .
Discussion
A genetic basis for the size polymorphism of CRI was sought by analyzing
CR 1 genomic polymorphismsthat were detected byapanel of restriction enzymes
CRI protein phenotype (n)
Pvu 11
5 .8 kb+
RFLP
5.8 kb-
FF (16) 8 8
FS (11) 11 0
SS (1) 1 0FIGURE 8 .
￿
Autoradiographs of the Southern blots in which CRI-2 was hybridized to the
Bam HI and EcoRI fragmentsofDNAfrom themembers of a family having theFFphenotype .
A Hind III digest of X DNA was used as a marker and the positions of these fragments are
designated on the left in kilobases . The positions of the 20- and 16-kb Eco RI restriction
fragments are shown on the right .
Lack ofCorrelation of the CRI Protein Phenotypes with Eco RI RFLP
WONG ET AL .
TABLE IV
154 1
and several cDNA and genomic probes . The cDNA probes hybridized to highly
homologous repetitive sequences, permitting the identification of multiple re-
striction fragments (17) . The relationships between the DNA and protein poly-
morphisms were defined by pedigree analyses and by assessment of coincidence
in the normal population . RFLPs were revealed by six enzymes and these RFLPs
could be divided into three categories according to their relationships to the
CRI allotypes. The RFLPs generated by Bam HI, Sac I (Figs . 2 and 4 ; Table I),
and EcoRV (Fig . 5) were found exclusively in association with a particular CRI
allotype and these may provide insight into the genetic mechanism for the
CR1 protein pheno-
type (n) 20 kb*
Eco RI RFLP
20 kb+/16 kb+ 16 kb*
FF (35) 10 20 5
FS (17) 5 7 5
FF' (1) 1 0 0
SS (4) 1 2 11542
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R1 20 ke 116 ke
￿
R1 20 kb'
￿
R1 20 kb' l16 kti
Bam 14.5 kti
￿
Bam 14.5 kb
￿
Bem 14 .5 kb ;
FIGURE 9.
￿
Cosegregation of the Eco RI polymorphism with the CRI-4`, 14.5-kb Barn HI
fragment and the S allotype.
occurrence of the S, F, and F' forms of the receptor. The RFLPs generated by
Hind III (Table II) and Pvu II (Fig. 7; Table III) were in linkage dysequilibrium
with, but not exclusively associated with, one or another of the CRI allotypes
and these may reveal evolutionary relationships between CRI genomic, struc-
tural, and quantitative polymorphisms. The RFLP revealed by Eco RI cosegre-
gated but was not in linkage dysequilibrium with CR 1 allotypes or the RFLPs
generated by other restriction enzymes (Figs. S and 9; Table IV), perhaps
reflecting a distal location within the large CRI gene or the presence of a
recombinational "hot spot" between the polymorphic Eco RI restriction site and
the rest of the CRI gene.
Among mechanisms that may account for the CR 1 allotypes differing by size,
three findings provided evidence for the insertion or deletion from the CR1
gene of segments containing introns and exons. First, the observation that two
restriction enzymes, Bam HI and Sac I, generated new restriction fragments in
20 of 21 individuals expressing the larger S allotype and in none of 35 individuals
having only the smaller F allotype indicated that the S allele differed from the F
allele by more than a single base pair (Figs. 2 and 4; Table I). Two individuals,
one of whom was Black (Fig. 2, donor 5), who expressed the S allotype but
lacked both characteristic Bam HI and Sac I polymorphisms, were not examined
further in this study, but this finding indicated that more than one mechanism
could lead to the production of the higher molecular weight S form of CRI .
Second, the S allele not only had new restriction fragments but also apparently
contained all Bam HI and Sac I fragments that were present in the F allele (Figs.
2 and 4). This observation suggested that the new restriction sites responsible
for the S-specific fragments were not located within a segment of the CR1 gene
that was common to both the S and F alleles. Third, the GB2PE genomic probe
derived from the S allotype-associated Bam HI fragment identified this 14.5-kb
fragment as being unique to the S allele (Fig. 2B). The additional finding that
this genomic probe and the GB 1 R1 genomic probe, both of which lacked human
repeat sequences and repetitive CR 1-coding sequences, hybridized to restriction
fragments other than those from which the probes were derived was further
evidence for the duplication of sequences within the CR1 gene (Figs. 2B andWONG ET AL.
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3B). The presence of highly homologous repeat sequences in both coding and
noncoding regions would suggest that homologous recombination with unequal
crossovers leading to the insertion and deletion of genomic sequences may be
the basis for the CR1 allotypes differing in the lengths of their polypeptide
chains. Ifthe S allele had been generated by unequal homologous recombination,
then negative selection may account for the lack of occurrence at comparable
frequencies of a corresponding shorter allele that constitutes the reciprocal
product of such an event. Although the F' allele may be the result of a loss.of
genomic sequences by similar mechanisms, further analysis ofthis allele has been
made difficult by our not having identified an F'F' homozygote among 358
persons.
Analysis of the CR1 transcripts associated with the three CR1 allotypes indi-
cated that these differed in size, having the samerankorder as thecorresponding
CR1 allotypes (Fig. 6). The F and S allotypes were each associated with two
transcripts differingby 1.4 kb, presumably reflecting alternative polyadenylation
sites. This circumstance precluded firm conclusions regarding the precise allo-
typic differences in the size of the CR1 transcripts. However, the apparent
minimal difference of 1.3-1.5 kb between the F', F, and S transcripts, respec-
tively, is sufficient to encode the 40-50 kd difference in the CR1 allotypes. Also,
the 1.4-kb allelic difference in transcript size is similar to the length of each of
four to fivehighly homologous repeat sequences ofCR1 cDNA thathave recently
been characterized (6), raising the possibility that the CR1 allotypes may differ
from each other by their number of homologous repeats. Additional evidence
for the possibility that repetitive sequences constitute the inserted or deleted
CR1 peptides is the absence of tryptic peptides that are unique for the CR1
allotypes (22). Further analysis of the genomic sequences unique to the S allele
will establish whether a genomic unit containing exons encodinga 50-kD peptide
has this apparent duplicative capacity.
The number of common CR1 alleles that we observed in this study was
expanded to 10 by use of the restriction enzymes, Hind III, Pvu II, and Eco RI.
A 7.4-kb Hind III fragment occurred in association with either F or S, whereas
the 6.9-kb Hind III fragment was associated only with F (Table II). The two
types of F alleles defined by the Hind III polymorphism could be further
subdivided by the presence or absence ofa 5.8-kb Pvu II fragment, whereas the
S allele was associated only with the presence of this 5.8-kb Pvu II fragment
(Table III). Thus, we saw four different alleles associated with the F allotype
whereas only a single S allele, in tight association with the 7.4-kb Hind III and
the 5.8-kb Pvu II fragments, was shown (Tables II and III; Fig. 10). These
findings might indicate that S evolvedrelatively recently or that negative selection
has limited the occurrence of the other potential types of S alleles. The least
complex scheme leading to the evolution of these different alleles and not
involving selection for or against particular genotypes can be proposed. Inde-
pendent mutations generated the 6.9-kb Hind III fragment and the 5.8-kb Pvu
II fragment and the combination of these in a single allele was the result of a
subsequent recombinational event (Fig. 10). The common polymorphism seen
with Eco RI showed no linkage dysequilibrium with any of the other RFLPs
despite cosegregating with the Bam HI polymorphism, and locating the site of1544
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H7 .4',P5.8 ,B14.5 ,R20'/16'
H7.4',P5 .8',B14.5 ,R20'/i6'
I H 7.4', P5.8', B 14.5', R20'/16'
H6.9',P5.8 -,B14 .5 - ,R20'/16'
H6.9',P5.8*,B14.5 _ ,R20/16'
FIGURE 10.
￿
Proposed scheme of evolution of the 10 common alleles of CR1 identified by
thecombination of different RFLPs. B14.5+ and B14.5- represent the RFLP defined by the
presence or absenceof the 14.5-kbBarn HI fragment hybridizing with CR1-4andcorrespond-
ing to the S and F allotypes, respectively. H7.4+ and H6.9+ represent the RFLP defined by
the allelic 7.4- and 6.9-kb Hind III fragments which correlate with the high and low CR1
number on erythrocytes, respectively. P5.8* and P5.8- represent the RFLP defined by the
presence andor absenceof the5.8-kbPvu 11 fragment. R20*/16* representstheRFLP defined
by the allelic 20- and 16-kb Eco RI fragmentsand indicates that either of the fragments can
be associated with each of thefive alleles defined by the otherrestriction enzymes. The relative
positions of theloci defined by thepolymorphic fragmentsare notknown. In this leastcomplex
scheme for the evolution of the CR1 alleles, independent mutations generated the alleles
containing the 5.8-kb Pvu II fragment and the 6.9-kb Hind III fragment. From the allele
containing the 5.8-kb Pvu II fragment,evolved theallele having the 14.5-kbBamHI fragment
associated with the S allotype. A recombinational event involving the alleles containing the
6.9-kb Hind III and the 5.8-kb Pvu II fragments, respectively, yielded the allele containing
both fragments.
this polymorphism in the CR 1 gene will determine whether distance or recom-
binational hot spots account for this finding. As has been shown (23-25) with
other complement proteins, these RFLPs in CR 1 may be associated with addi-
tional allotypes that can be visualized by the use of analytical procedures that
separate proteins on the basis of charge rather than size. Furthermore, the
relatively high number and frequency of CRI alleles makes this locus a useful
marker system (26) for the long arm of chromosome 1 to which the CR1 gene
maps (27).
Summary
Human CR1 exhibits an unusual form of polymorphism in which allotypic
variants differ in the molecular weight of their respective polypeptide chains. To
address mechanisms involved in the generation of the CR1 allotypes, DNA from
individuals having the F allotype (250,000 Mr), the S allotype (290,000 Mr), and
the F' allotype (210,000 Mr) was digested by restriction enzymes, and Southern
blots were hybridized with CRI cDNA and genomic probes . With the use of
Bam HI and Sac I, an additional restriction fragment was observed in 20 of 21
individuals having the S allotype with no associated loss of other restriction
fragments. Southern blot analysis with a noncoding genomic probe derived from
the S allotype-specific Bam HI fragment showed hybridization to this fragment
and to two other fragments that were also present in FF individuals. Thus, an
intervening sequence may be repeated twice in the F allele and three times inthe S allele. A restriction fragment length polymorphism (RFLP) unique to two
individuals expressing the F' allotype was seen with Eco RV, but the absence of
persons homozygous for this rare allotype prevented further comparisons with
the F and S allotypes. Analysis of the CR 1 transcripts associated with the three
CR1 allotypes indicated that these differed by 1 .3-1 .5 kb and had the same rank
order as the corresponding allotypes. Taken together, these findings suggest that
the S allele was generated from the F allele by the acquisition of additional
sequences, the coding portion of which may correspond to a long homologous
repeat of ^-1 .4 kb that has been identified in CR1 cDNA.
We saw two other RFLPs with Hind III and Pvu 11 that were in linkage
dysequilibrium with the Bam HI-Sac I RFLPs associated with the S allotype, and
a third polymorphism was seen with Eco RI that was not in linkage dysequilibrium
with the other polymorphisms. Thus, 10 commonly occurring CR1 alleles can
be defined, making this locus a useful marker for the long arm of chromosome
1 to which the CR1 gene maps.
Receivedfor publication 7July 1986.
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